Data Patterns reports a robust 55% growth in EBITDA and 40% growth in PAT in FY Q4 FY 2023-24

▴ Data Patterns
The Board has recommended a final dividend of Rs. 6.50 per share (325% per equity share of Rs. 2 each), which is subject to approval by the shareholders in the ensuing AGM.

Chennai, May 18, 2024: The Board of Directors at (India) Limited (NSE: DATAPATTNS | BSE: 543428), a strategic Defense and Aerospace electronics systems provider catering to the indigenously developed defense products industry, today approved the limited review financial results for the quarter and financial year ended March 31, 2024.

 

Performance Highlights

INR in Cr.

Particulars

FY 23-24

FY 22-23

Q4 FY 24

Q3 FY 24

Total Income

565.8

462.7

194.6

150.8

Revenue from Operations

519.8

453.4

182.3

139.5

Operational EBIDTA

221.6

171.8

93.0

60.0

Profit Before Tax (PBT)

242.2

164.8

95.3

65.7

Profit After Tax (PAT)

181.7

124.0

71.4

51.0

 

FY 2023 – 2024

  • Total Revenue for FY 2023-24 increased by 22% from Rs. 463 Cr to Rs. 566 Cr in FY FY 2022-23.
  • Revenue from operations increased by 15% to INR 520 Cr in FY 24 as against INR 453 Cr in FY23
  • EBITDA grew by 29% to INR 222 Cr in FY24 as against INR 172 Cr in FY23
  • PBT for FY24 grew by 47% to INR 242 Cr as against INR 165 Cr in FY23
  • Profit after Tax for FY24 was Rs. 182 Cr as against Rs. 124 Cr in FY 23, marking 47% growth.
  • PAT margin for FY 2024 was 35% against 27% in FY 2023

 

Q4 FY 2024 in comparison to Q3

  • Total Revenue for Q4 FY 2023-24 increased by 29% from Rs. 151 Cr to Rs. 195 Cr as compared to Q3.
  • Revenue from operations increased by 31% to INR 182 Cr in Q4 FY 24 as against INR 140 Cr in Q3 of FY24
  • EBITDA grew by 55% to INR 93 Cr in Q4 FY24 as against INR 60 Cr in Q3 FY24
  • PBT for Q4 FY24 grew by 45% to INR 95 Cr as against INR 66 Cr in Q3 FY24
  • Profit after Tax for Q4 FY24 was Rs. 71 Cr as against Rs. 51 Cr in Q3 FY24, an increase of 40%.

 

The Board has recommended a final dividend of Rs. 6.50 per share (325% per equity share of Rs. 2 each), which is subject to approval by the shareholders in the ensuing AGM

 

ORDER BOOK

  • Company has secured more than Rs. 670 Cr of orders during FY 2023-24.
  • Order book as on March 31, 2024 - Rs. 1,083.01 Cr
  • Orders received during Q1 FY 2024-25 so far - Rs.        29 Cr
  • Negotiation completed & yet to receive order - Rs.      80 Cr
  • Including orders negotiated converted into orders, the order book will be INR 1096 Cr
  • Order book as on April 01, 2023 was Rs. 924 Cr

 

From the CMD’s Desk

Commenting on the company’s performance, Mr. Srinivasagopalan Rangarajan, Chairman & Managing Director, Data Patterns (India) Limited said, “I am pleased to report that we had a successful FY 2023-24. Our EBITDA increased by 29% and PAT increased by 47% in FY 2023-24, marking significant growth compared to last year. Order inflows have aligned with our guidance, with deliveries scheduled for next quarter. Going forward, we remain committed to excellence and innovation in product development, leveraging opportunities in the Indian defence sector.”

 

About Data Patterns

Data Patterns’ core competencies include design and development across electronic hardware, software, firmware, mechanical, product prototype besides its testing, validation and verification. Its involvement has been across Radars, Electronic Warfare Suites, Communications, Avionics, Small Satellites, Automated Test Equipment, COTS and programmes catering to Tejas Light Combat Aircraft, Light Utility Helicopter, BrahMos and other Communication & Electronic Intelligence Systems.

The company works closely with the defence PSUs such as Hindustan Aeronautics Ltd and Bharat Electronics Ltd as well as government organisations involved in defence and space research like DRDO and ISRO.

For further information, kindly contact:

 

Prakash Raja (Company Secretary)

Data Patterns (India) Limited

E-mail: investor.relations@datapatterns.co.in

Vijay Shekhar

Concept PR

M: +91 97890 52198

 

DISCLAIMER:

Certain statements that are made in the Press Release may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, inflation, litigation, etc. Actual results might differ substantially from those expressed or implied. Data Patterns (India) Limited will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026